Cue Health, connected medical diagnostics, $235M Private Equity round with CAVU, J & J Innovation, Perceptive Advisors, ACME Capital, Koch Strategic Platforms
AttackIQ, security optimization platform, $42M Series C
Phanes Therapeutics, oncology and eye disease, $40M Series B with Sequoia Capital China, Delos Capital, Dyer Capital, Volcanics Ventures
Juno Diagnostics, accessible genetic testing, $25M Series A with Perceptive Advisors
Mindera Dx, skin cancer therapies, $12.6M with Rockmont Investments, Mountain Group Capital, Scientific Development Health Partners
CeleCor Therapeutics, novel molecule inhibitor, $1M Series Seed